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GINS, a heterotetramer of SLD5, PSF1, PSF2, and PSFS proteins, is an emerging 
chromatin factor recognized to be involved in the initiation and elongation step 
of DNA replication. Although the yeast and Xenopus GINS genes are well docu- 
mented, their orthologous genes in higher eukaryotes are not fully characterized. 
In this study, we report the genomic structure and transcriptional regulation of 
mammalian GINS genes. Serum stimulation increased the GINS mRNA levels 
in human cells. Reporter gene assay using putative GINS promoter sequences 
revealed that the expression of mammalian GINS is regulated by 17P-Estradiol- 
stimulated estrogen receptor a, and human PSFS acts as a gene responsive to 
transcription factor E2F1. The goal of this study is to present the current data so 
as to encourage further work in the field of GINS gene regulation and functions 
in mammalian cells. 
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Introduction 
In eukaryotic cells, chromosomal DNA replication re- 
quires the formation of a prereplicative complex (pre- 
RC) on origins, and assembly of other replication 
proteins in the S phase of the cell cycle to load the 
DNA polymerases to initiate DNA synthesis (1 ). The 
Cdc45 protein is crucial for the latter step of DNA 
replication initiation, as it activates the pre-RC that 
contains the MCM helicase. In addition to these pro- 
teins, GINS, a heterotetramer consisting of SLD5, 
PSFl (partner of Sld five l), PSF2, and PSF3 pro- 
teins, was recently identified as a loading factor for 
DNA polymerases, and as being required to separate 
the DNA strands at the replication fork in yeast and 
Xenopus egg extracts (2-6). Although GINS is sup- 
posed to play a significant role in eukaryotic cells, the 
biological functions of its orthologous genes in higher 
eukaryotes are not fully characterized. A comparative 
genomic approach for the study of the GINS ortholo- 
gous genes in higher eukaryotes could help in the un- 
derstanding of a common regulatory mechanism for 
mammalian GINS genes. 
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In this study, we characterized the human and 
mouse GINS orthologous genes by using bioinformat- 
ics techniques. The gene structures, chromosomal 1o- 
calization, protein homology, and expression profiles 
are discussed. In addition, transcriptional regulations 
of human and mouse GINS genes are characterized. 
This is the first report of the identification of GINS 
up-regulation by serum stimulation and 17P-Estradiol 
(E2)-stimulated estrogen receptor a (ERa), and also 
is the first report that the putative promoter region 
of human PSF3 is responsive to transcription factor 
E2F1. 
Results 
Characterization of the GINS ortholo- 
gous genes in higher eukaryotes 
To investigate the functional importance of the GINS 
proteins in higher eukaryotes, we initially compared 
the amino acid sequences among human, chimpanzee, 
orangutan, dog, cow, mouse, and rat GINS proteins. 
As summarized in Table 1, human PSF1, PSF2, 
PSF3, and SLD5 proteins showed 92%-94%, 86%- 
loo%, 89%-99%, and 84%-88% total amino acid iden- 
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tity, respectively, with the mammalian orthologous were well conserved. Human (mouse) PSF1, PSF.2, 
genes. Next, we sought to determine the gene struc- PSF3, and SLDS genes had 7 (7),  5 (5), 3 (3), and 
tures of the human and mouse GINS genes. For this 8 (8) exons, respectively (Tables 2-5). The pre- 
purpose, we searched for a genome database using hu- cise exon-intron boundaries of the human and mouse 
man and mouse GINS cDNAs as query sequences in GINS genes were determined based on the consen- 
the BLAST program. Consequently, human (mouse) sus sequence (“gt. . . ag” rule of intronic sequence) 
PSFl,  PSF2, PSF3, and SLDS gene fragments were of exon-intron junctions and the codon usage. One 
identified within the genome sequences NT-011387 exception was found in intron2 (“gg. . . ag”) of the 
(AL808125), NT-010498 (AC103360), NT-086851 human PSF3 gene (Table 4). The human (mouse) 
(AC113951), and NT-086740 (AC126038), respec- PSFl,  PSFZ, PSF3, and SLDS genes were mapped 
tively. The gene structures, especially the exon length to 20~11.21 (2G3), 16q24.1 (8E1), 16q21 (8C5), and 
and location of the human and mouse GINS genes 8~11.21 (8A3), respectively (Table 6). 
Table 1 Conservation of Amino Acids in the GINS Proteins* 
Mammal PSFl PSF2 PSF3 SLD5 
Identify (%) ORF (aa) Identify (%) ORF (aa) Identify (%) ORF (aa) Identify (%) ORF (aa) 
Human 100 196 100 185 100 216 100 223 
Chimpanzee 92 268 100 185 99 216 
- 99 216 Orangutan - - - 
- - 
- - 
Dog 94 196 94 185 94 216 88 292 
cow 92 196 86 340 93 216 84 489 
Mouse 92 196 92 185 89 216 87 223 
Rat 93 196 92 434 90 216 88 223 
*The percentage conservation in mammals, including chimpanzee, orangutan, dog, cow, mouse, and rat proteins relative 
to the sequence of the human protein (taken as 100%) is presented. The lengths of the amino acid (aa) sequences are 
indicated. “-” indicates that the protein is not deposited in the databases. 
Table 2 Exon-Intron Structures of the Human PSFl and Mouse Psfl Genes* 
Exon Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
No. 
1 
2 
3 
4 
5 
6 
7 
Exon 
boundaries of human PSFl gene 
AGCGCG-TTCAAC gtgagg 
ttctag GAGGAT-TGATGT gtaagt 
tatcag GAATGA-ATACCT gtaagc 
tcctag GTATGA-GAAGAA gtgagt 
ttgcag ATGGAG-ATTGAA gtatgt 
tttcag GTCCGG-AGCCAG gtattt 
cctcae: CACTTT-ATGGAG 
in human genome sequence 
25328321-25328531 of NT-011387 
25334426-25334490 of NT-011387 
25337740-25337838 of NT-011387 
25338741-25338831 of NT-011387 
25345847-25345963 of NT-011387 
25362338-25362412 of NT-011387 
2536655S25367702 of NT-011387 
(bP) 
211 
65 
99 
91 
117 
75 
1.144 
(bP) 
5,896 
3,251 
904 
7,017 
16,376 
4,148 
~~~~~ ~ 
Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
No. boundaries of mouse Psfl gene in mouse genome sequence (bP) (bP) 
1 GGAGCT-TTTAAT gtgagg 76468-76660 of AL808125 193 2,989 
2 tttcag GAGGAC-TGATGT gtaagt 79648-79712 of AL808125 65 3,292 
3 tctcag GAATGA-ATACCT gtgagt 83003-82101 of AL808125 99 1,636 
4 tcctag GTATGA-GAAGAA gtaagt 84736-84826 of AL808125 91 7,924 
5 tcacag ACGGAG-ATTGAA gtatgt 92749-92865 of AL808125 117 2,045 
6 tttcag GTGCGG-AGTCAG gtagtt 94909-94983 of AL808125 75 2,726 
7 ttgtag CACTTT-TTTCAC 97708-98145 of AL808125 438 
*The nucleotide sequences around the exon-intron boundaries are shown in upper-case (exon) and lower-case letters 
(intron). The exon and intron lengths (bp) are shown. 
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Table 3 Exon-Intron Structures of the Human PSFZ and Mouse PsfZ Genes 
Exon Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
1 GCGGCC-ATCGGG gtgagg 39336779-39336614 of NT-010498 116 1,236 
2 tggcag GGGGAC-ATGTAG gtaagg 39335379-39335265 of NT-010498 115 5,780 
3 ttttag AAAAGT-AAATCA gtaagt 39329486-39329387 of NT-010498 100 2,917 
4 ctttag TGCTTC-GCCAAG gtaggt 39326471-39326345 of NT-010498 127 204 
No. boundaries of human PSF2 gene in human genome sequence (bP) (bP) 
5 ctttag CTGGAT-AACTCA 39326142-39325479 of NT-010498 664 
Exon Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
1 GGGAAA-ATCGGG gtgagc 111624-111788 of AC103360 165 88 
2 ttgcag GGGGAC-ATGTGG gtgagc 111875-111989 of AC103360 115 2,534 
3 tcagag AGAAAC-GAATCA gtgagt 114522-114621 of AC103360 100 3,886 
4 cttcag TGCTTC-GCCAAG gtaggc 118506-118632 of AC103360 127 272 
No. boundaries of mouse Psf2 gene in mouse genome sequence (bP) (bP) 
5 tttcag CTGGAC-TATACT 118903-122081 of AC103360 3,179 
Table 4 Exon-Intron Structures of the Human PSFS and Mouse PsfS Genes 
Exon Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
No. boundaries of human PSF3 gene in human genome sequence (bp) (bp) 
1 CCGCTT-CCACAG gtgagc 2010301-2010569 of NT-086851 269 9,759 
2 ctgcag GGTTCC-CTGCAG ggcaag 2020327-2020560 of NT-086851 234 1,169 
Exon Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
No. boundaries of mouse Psf3 gene in mouse genome sequence (bp) (bp) 
1 GAGTTT-CCTCAG gtgagg 126499-126244 of ACll3951 256 4,028 
2 acgcag GGTACA-CTGAAG gtaagt 122217-121984 of AC113951 234 5,061 
3 tcccag ACTTTT-TTAGCA 2021728-2023378 of NT-086851 1,651 
3 cctcae ACTTTT-GCCTGC 116924-115517 of AC113951 1,407 
Table 5 Exon-Intron Structures of the Human SLD5 and Mouse Sld5 Genes 
Exon Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
1 GCGACT-CCCCGA gtgagc 28874824-28874993 of NT-086740 170 789 
2 cattag GTTCCT-GAGCAG gtaagc 28875781-28875895 of NT-086740 115 6,063 
3 ttttag GCCTGG-CACATG gtaaga 28881957-28882043 of NT-086740 87 735 
4 taatag GAAGAA-ATGAAG gtttga 28882777-28882890 of NT-086740 114 2,436 
5 tcacag ATAGAG-CAGAGA gtgagt 28885325-28885422 of NT-086740 98 142 
6 tttcag GTTCAT-GGGCAG gtaaac 28885563-28885651 of NT-086740 89 1,851 
No. boundaries of human SLD5 gene in human genome sequence (bP) (bP) 
7 tggcag TTCCCA-GCAGAG gtgagt 28887501-28887591 of NT-086740 91 93 
8 tttcag GGACTA-AAAAAA 28887683-28888085 of NT-086740 403 
~~~ 
Exon Nucleotide sequence around exon-intron Nucleotide position of exon Exon Intron 
1 GTGTTT-TGCGAG gtgagc 79323-79134 of AC126038 190 372 
2 tttcag GTGTAG-GAGCAG gtaagc 78763-78644 of AC126038 120 2,141 
3 ttttag GCCTGG-CACATG gtaaga 76504-76418 of AC126038 87 2,037 
4 taatag GAAGAA-ATGAAG gtttga 74382-74269 of AC126038 114 2,903 
5 tcacag ATAGAG-CAAAGA gtaagt 71367-71270 of AC126038 98 103 
6 ttccag GTATAT-GGGCAG gtaaga 71168-71080 of AC126038 89 2,078 
No. boundaries of mouse Sld5 gene in mouse genome sequence (bP) (bP) 
7 tggcag TTCCCA-GCAGAG gtgagt 6900348913 of AC126038 91 75 
8 tttcag AGACTA-AAGCTT 68839-68289 of AC126038 501 
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Table 6 Chromosomal Localization of the Human and Mouse GINS Genes 
PSFl PSF2 PSF3 SLD5 
Human 20~11.21 16q24.1 16q21 8~11.21 
Mouse 2G3 8E1 8C5 8A3 
Expression profiles of human and 
mouse GINS mRNAs 
In silico analysis revealed that the expression patterns 
of the GINS mRNA in human/mouse tissues and or- 
gans were quite different (Figure 1A). On the other 
hand, during the developmental stages, the GINS 
mRNA expression patterns were quite similar: high- 
est in the embryo and juvenile stages, lower in adults, 
and no expression in the neonatal stage (Figure 1B). 
Next, we attempted a search for GINS mRNA in pub- 
lic databases. The Gene Expression Omnibus (GEO) 
database search revealed that the SLD5 gene is down- 
regulated under two growth arrest conditions, namely, 
serum deprivation and contact inhibition, in T98G 
cancer cells (Accession No. GDSSll), and PSFl is an 
estrogen target in human breast carcinoma MCF7 
cells (Accession No. GDSll8). It is of interest that 
GINS is regulated by serum stimulation, because the 
mRNA level of a known DNA replication initiator 
is reported to be induced when cells enter the G1/S 
phase of the cell cycle (7,B).  To substantiate this ev- 
idence, growth arrest of Sms-2 cells was induced by 
incubation in serum-free medium for three days, then 
the cells were re-entered into the cell cycle with the 
readdition of 20% fetal bovine serum (FBS). Twenty- 
four hours after the serum re-addition, the GINS 
mRNA level was found to be up-regulated, while the 
GAPDH mRNA level remained unchanged (Figure 
1C). At this time point, cyclin A protein accumula- 
tion was clearly observed as the cells re-entered the 
cell cycle (data not shown). 
Transcriptional regulation of the human 
and mouse GINS genes 
To gain more insights into the functions of the human 
and mouse GINS genes, we searched the proximal re- 
gion of the transcription start site for potential cis- 
elements using the Transfac software (ver. 4.0, cut-off 
85). The E2F- and/or NF-Y-binding consensus se- 
quences were identified to be surrounded by GC-rich 
sequences in the putative promoter region of the hu- 
man and mouse GINS genes (Figure 2A). In addition 
to that by serum stimulation, many genes involved 
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in DNA replication initiation were found to be regu- 
lated by transcription factor E2F1 (7 ,B ) .  To demon- 
strate the importance of the putative E2F-binding el- 
ement in the basal promoter activity, we generated 
human PSFl,  mouse Psf . ,  human PSF3, and mouse 
Sld5 promoter-luciferase constructs. As shown in 
Figure 2B, human PSFl,  mouse Ps f . ,  human PSF3, 
and mouse Sld5 promoter constructs showed approx- 
imately 265-, 37-, 0.6-, and 82-fold increases in ac- 
tivity, respectively, as determined by measuring the 
relative luciferase activities, taking the activity in the 
control luciferase vector pGL3-Basic as 1. Exogenous 
coexpression of E2F1 caused up to approximately 1-, 
0.2-, 8.3-, and 0.9-fold increases in the human PSFI, 
mouse Psf2, human PSF3, and mouse Sld5 promoter 
activities, respectively, as compared to that of the 
pcDNA3 control vector (Figure 2C). These results 
suggest that the E2F-binding motif plays critical roles 
in the E2F1-mediated human PSF3 promoter activ- 
ity. This is the first report of the E2F1-dependent 
regulation of the PSF3 gene. 
To determine whether E2 also regulates GINS pro- 
moter activity, HeLa cells were cultured with E2, and 
the effect of cotransfection with ERa was measured. 
Interestingly, the initial transient transfection studies 
with pGL3-hPSF1, -mPsf2, -hPSF3, and -mSld5 re- 
porter vector constructs showed that treatment with 
100 nM of E2 resulted in 1.2-, 0.8-, 1.3-, and 0.9- 
fold increases in the reporter gene activities, respec- 
tively, as compared to that after DMSO treatment 
(Figure 2D). However, following cotransfection with 
ERa, there was an enhanced (ll-24-fold) induction 
of reporter gene activity after treatment with 100 nM 
of E2 as compared to that in the pcDNA3 control vec- 
tor (Figure 2D). These results suggest that the GINS 
genes are regulated by E2 via ERa in cultured cells. 
Discussion 
In the present study, we attempted to characterize the 
gene structure and transcriptional regulation of the 
human and mouse GINS genes. Studies using bioin- 
formatics techniques revealed that the GINS proteins 
are well conserved among several mammals. In addi- 
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Fig. 1 Expression profiles of GINS genes. A search was conducted based on the EST counts in human/mouse tissues 
(A) and during the developmental stages (B) in the UniGene database (EST Profile Viewer, NCBI). The datasets 
used for PSF1, PSFZ, Psf3, and SLD5 genes were Hs. 360033, Hs. 433180, Mm. 35546, and Hs. 521557, respectively. 
The number of transcripts per million was calculated from the gene EST/total EST in the pool. C. Semi-quantitative 
RT-PCR analysis of the transcripts of GINS genes in Sms-2 cells after serum stimulation for 24 h. The number of 
PCR cycles is shown in parentheses. The housekeeping gene, GAPDH, was used as the control. 
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Fig. 2 Transcriptional regulation of the human and mouse GINS genes. A. Schematic representation of the vicinity 
of the transcription start sites of the human and mouse GINS genes. The putative transcription factor E2F- (closed 
isosceles triangles) and NF-Y-binding sites (open isosceles triangles) are indicated with their scores (maximum score 
100) calculated by the Transfac program. Exon 1 (open boxes) is indicated. Scale bar equals 500 bp. B. Human and 
mouse GINS promoter activities in asynchronously growing human cells. HeLa cells were transfected with 200 ng of 
reporter constructs and 400 ng of the expression vector for E2F1, together with 0.6 ng of pRL-TK. The pcDNA3 vector 
was used as the negative control. At 48 h after the transfection, the cells were harvested, and extracts were prepared 
to measure the firefly and Renilla luciferase activities. Values are represented as relative luciferase activities, with that 
of pGL3-Basic being taken as 1. C .  The E2F-binding motif of the PSF3 promoter is sufficient to confer responses 
to ectopic E2F expression. The experiment was performed as described in panel B. Values are represented as relative 
luciferase activities, with that of the control vector pcDNA3 being taken as 1. Statistically significant ( P  < 0.05) 
induction is indicated by an asterisk. D. E2-induced activation of GINS promoter constructs in HeLa cells. Cells were 
transfected with the indicated reporter plasmids and pcDNA3 or pSG5-ERa expression vector, and the effects of E2 
or DMSO on the luciferase activities were determined. Results are expressed as mean&S.D. for at least three triplicate 
determinations for each treatment group. Statistically significant ( P  < 0.05) induction is indicated by an asterisk. 
tion, conservation of the gene structure, including the 
putative promoter region between human and mouse 
GINS genes, suggests that their transcriptional regu- 
lation might also be similar. We succeeded in identify- 
ing PSF3 as an E2F1-regulated gene, and that the hu- 
man and mouse GINS genes are regulated by growth 
stimuli, including serum addition and E2 treatment. 
In contrast to the rapid progress of research on the 
yeast and Xenopus GINS, only a few reports have 
been published regarding mammalian GINS. For ex- 
ample, mice homozygous for the PSFl gene died in 
utero around the time of implantation, indicating that 
PSFl protein may be required during early embryo- 
genesis ( 9 ) .  cDNA microarray analyses revealed that 
the PSF2 gene is frequently up-regulated in cholan- 
giocarcinoma, suggesting that PSF2 protein may play 
an important role in the development of this type of 
liver cancer ( 1  0). 
The action of E2 on its target cells is mediated 
via ERa or ERP, which function as ligand-activated 
transcription factors regulating gene expression. E2 
has been shown to play a central role in breast can- 
cer development; therefore it is important to find out 
the critical downstream targets of E2/ERol action. 
The majority of E2 target genes are characterized by 
imperfect estrogen-responsive element (ERE: AGGT- 
CANNNTGACCT) sequences or complex organiaa- 
tion with the presence of half an ERE site. Interest- 
ingly, many E2-responsive genes, which do not contain 
ERE but do contain other &-elements, such as Spl, 
have also been described. ERs can regulate transcrip- 
tion by direct protein-protein interaction with Spl 
(11) .  Indeed, the GINS promoter constructs used in 
this study contained GC-rich sequences, but no ERE- 
like sequences. The mitogenic effect of ERa is me- 
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diated at the regulation level of kinases that govern 
the transition from the GO/G1 to S phase of the cell 
cycle, such as under the influence of cyclin D-Cdk4/6 
and cyclin E-Cdk2, to increase phosphorylation of the 
retinoblastoma protein (pRb) (12) .  pRb physically 
interacts with E2F1 to yield a transcriptionally re- 
pressed complex. Phosphorylated pRb results in dis- 
sociation of the pRbE2F1 complex and subsequent 
up-regulation of E2F1-dependent genes (13-1 5). Al- 
though the regulation of E2F1-dependent transactivai 
tion is closely linked to pRb, E2 is also known to in- 
duce E2F1 mRNA and protein in human cultured cells 
(16) .  This could mean that the E2F1-dependent regu- 
lation of PSF3 expression may be partially mediated 
by E2. More detailed studies are needed to clearly 
elucidate the mechanism by which GINS affects the 
development of breast cancer. 
In conclusion, our study clearly demonstrated that 
a comparative genomic approach for the GINS or- 
thologous genes in higher eukaryotes could help in 
the understanding of common or unique regulatory 
mechanisms for important genes. We identified the 
conserved gene structure and for the first time charac- 
terized the promoter region of the human and mouse 
GINS genes. This is the first report of the iden- 
tification of the induction of GINS by serum stim- 
ulation and E2/ERol-induced genes, and is also the 
first report that human PSF3 gene is regulated by 
transcription factor E2F1. 
Materials and Methods 
Bioinformatics 
Bioinformatics techniques were employed as pre- 
viously described (17, 18). A search for GINS 
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orthologous genes was conducted using the Ho- 
moloGene or BLAST program at NCBI (http:// 
www.ncbi.nlm.nih.gov/). The Transfac software 
(ht t p: //mot i f.genome. jp/ ) was used to determine the 
transcription factor binding elements. The search 
was conducted based on the expression profile sug- 
gested by analysis of the EST (expressed sequence 
tag) counts in human/mouse tissues and organs in the 
UniGene database (EST Profile Viewer, NCBI). The 
datasets used for PSF1, PSF2, Psf3, and SLD5 genes 
were Hs. 360033, Hs. 433180, Mm. 35546, and Hs. 
521557, respectively. The number of transcripts per 
million was calculated based on the gene EST/total 
EST in the pool, and this value was exported to an 
Excel file. The expression profile suggested by analy- 
sis of Affymetrix GeneChip or SAGE (serial analysis 
of gene expression) was confirmed by using the GEO 
database search at NCBI. 
Plasmids 
The human and mouse GINS promoter frag- 
ments were generated by polymerase chain reac- 
tion (PCR) from genomic DNA and ligated into 
the pGL3-Basic vector (Promega, Madison, USA). 
Initial PCR primers were designed to amplify 548 
(-14/+301), and 499 bp (-409/+90) of human 
PSFl (GenBank Accession No. AL353812), mouse 
Psf2 (GenBank Accession No. AC103360), human 
PSF3 (GenBank Accession No. AC009118), and 
mouse Sld5 (GenBank Accession No. AC147247) 
promoter sequences, respectively, which are num- 
bered relative to the transcription initiation site at 
+1 described in the NCBI UniGene database. The 
forward (F) and reverse (R) PCR primers for the 
promoter constructs were: 5’-gcagtccctaccagcactag- 
3’ (-427F), 5’-cggccttgccaaccacca-3’ (+121R), 5’- 
acccggagctgac t t tga-3’ ( - 6 13F), 5’-gcagcgcct c aggcact t- 
3’ (+25R), 5’-tcctgtctgatgcgtccc-3’ (-14F), 5’- 
tgcgct ccgctccaggaa-3’ ( + 30 1 R) ,5’- t agagaacaact ctgcgc- 
3’ (-409F), and 5‘-agcggtgggcgccggaga-3’ (+90R), re- 
spectively. The forward/reverse PCR primers added 
BglII/HindIII (for PSFl and Sld5) or KpnIIBglII 
(for Psf2 and PSF3) sites to facilitate subcloning. 
The pcDNA3-HA-E2Fl expression plasmid was a 
generous gift from Dr. Joseph R. Nevins (Duke Uni- 
versity, Durham, USA). The pSG5-ERa expression 
plasmid was kindly provided by Dr. Gary H. Perdew 
(The Pennsylvania State University, Univeristy Park, 
USA). 
bp (-427/+121), 638 bp (-613/+25), 315 bp 
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Cell culture and reporter assay 
HeLa and Saos-2 cells were cultured in Earle’s 
modified Eagle’s medium (MEM) supplemented with 
10% FBS and penicillin/streptomycin. To measure 
the growth-dependent induction of the human GINS 
gene expression, growth of the Saos-2 cells was ar- 
rested in the GO phase by incubation in the absence 
of FBS for 3 d, and the cells were reintroduced into 
the cell cycle by culturing with 20% FBS. Total RNA 
and cell lysates were recovered at 0 and 24 h after 
the serum stimulation. To measure promoter activ- 
ity, the cells were transfected with FuGENE6 (Roche, 
Indianapolis, USA) according to the manufacturer’s 
instruction. Briefly, 400 ng of expression plasmid, 
200 ng of firefly luciferase reporter plasmid (pGL3, 
Promega), and 0.6 ng of Renilla luciferase reporter 
plasmid (pRL-TK, Promega) per 24-well dish were 
used in each transfection. After 24 h, cells were 
treated with 100 nM of E2 (Sigma, St. Louis, USA) 
or DMSO for 34-40 h. The cells were harvested, 
and luciferase assay was performed using the Dual- 
Luciferase Reporter Assay System following the man- 
ufacturer’s protocol (Promega). Experiments were 
done at least in triplicate, and the relative activi- 
ties and S.D. values were determined. To control for 
transfection efficiency, firefly luciferase values were 
normalized to the values for Renilla luciferase. 
RT-PCR 
Total cellular RNA was extracted from Saos-2 cells 
using Trizol reagent (Invitrogen, Carlsbad, USA) ac- 
cording to the manufacturer’s instruction. RT-PCR 
was performed with the Superscript RT-PCR system 
according to the manufacturer’s instruction (Invitro- 
gen). PCR was performed as follows: denaturation 
at 94°C for 2 min, followed by multiple cycles at 
94°C for 15 s, 55°C for 30 s, and 68°C for 30 s. 
The following primers were used: PSFl (GenBank 
Accession No. NM-021067), 5’-tgagatcacaggcgtgac- 
3’ and 5’-ctgtccccttccaaagtg-3’; PSFS (GenBank Ac- 
cession No. NM-016095), 5’-cagcctctggagagtact-3’ 
and 5’-cacctctgtgagagagtc-3’; PSFS (GenBank Ac- 
cession No. NM-022770), 5’-ctgcctgcagggagttac-3’ 
and 5’-agagggcccttcatagtc-3’; SLD5 (GenBank Acces- 
sion No. NM-032336), 5‘-gcctctcgccggaagagt-3’ and 
5‘-cctgacctcatgatccgc-3’. As a control, a GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase) primer 
set was used (R&D Systems, Minneapolis, USA). The 
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amplified products were separated on 1% agarose gels 
and visualized under ultraviolet transillumination. 
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